SCHEMBL5992997

SCHEMBL5992997

Cc1cc(C)c2c(n1)sc1c(=O)nc[nH]c12

nearest known ligand 0.56

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 5/20 0.56
ALDH1A1 P00352 4/20 0.56
HPGD P15428 3/20 0.56
POLB P06746 3/20 0.56
MEN1 O00255 1/20 0.56
USP2 O75604 1/20 0.56
GLA P06280 1/20 0.56
BLM P54132 1/20 0.56
KMT2A Q03164 1/20 0.56
HSD17B10 Q99714 1/20 0.56
TDP1 Q9NUW8 1/20 0.56
L3MBTL1 Q9Y468 1/20 0.56
GAA P10253 2/20 0.48
CHRM4 P08173 11/20 0.48
CDC7 O00311 1/20 0.46
PLK4 O00444 1/20 0.46
IKBKB O14920 1/20 0.46
AURKA O14965 1/20 0.46
CHUK O15111 1/20 0.46
ROCK2 O75116 1/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL273173 0.78 CHRM4 (0.57) KDM4EALDH1A1HPGDPOLBKMT2A
SCHEMBL5730415 0.73 KDM4E (0.63) KDM4EALDH1A1HPGDPOLBMEN1
SCHEMBL30410968 0.72 CDC7 (0.51) KDM4EALDH1A1HPGDPOLBMEN1
SCHEMBL14784887 0.70 CHRM4 (0.56) KDM4EALDH1A1HPGDPOLBMEN1
SCHEMBL432011 0.68 KDM4E (0.67) KDM4EALDH1A1HPGDPOLBMEN1
SCHEMBL2300776 0.67 ALDH1A1 (0.34) KDM4EALDH1A1HPGDPOLBMEN1
SCHEMBL18666379 0.66 HPGD (0.53) KDM4EALDH1A1HPGDPOLBMEN1
SCHEMBL278791 0.66 POLB (0.65) KDM4EALDH1A1POLBKMT2AGAA
SCHEMBL30989229 0.66 KDM4E (0.66) KDM4EALDH1A1HPGDPOLBMEN1
SCHEMBL14794166 0.65 CHRM4 (0.60) KDM4EALDH1A1HPGDPOLBMEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20060014144-A1 Pseudonucleotide comprising an intercalator HUMAN GENETIC SIGNATURES PROPRIETARY LTD. (AU) 2006-01-19 US disclosed
WO-2003052133-A2 OLIGONUCLEOTIDE ANALOGUES COMPRISING INTERCALATOR PSEUDONUCLEOTIDES HUMAN GENETIC SIGNATURES PTY LTD (AU) 2003-06-26 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20060014144-A1 Pseudonucleotide comprising an intercalator POLN, POLRMT, SUB1 KDM4E 3483/4885ALDH1A1 1636/4885HPGD 3063/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.